Active13826151Private limited companyLondon

BEYOND BLOOD DIAGNOSTICS LTD

Significant control: Manfredi Giovanni San Martino D'Aglie Di San Germano (75–100%), Christoph Franz Schmidt (significant control) and 1 more

Companies HouseCompanies House

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Watch this company

Get an email when Companies House records a change for Beyond Blood Diagnostics Ltd: status, filings, accounts, officers or owners. Free.

Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy

Coming soon · product and service lists

What does Beyond Blood Diagnostics Ltd sell?

Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01

Summary

Generated from filed data · no estimates

BEYOND BLOOD DIAGNOSTICS LTD is an active private limited company (company number 13826151) incorporated on 4 January 2022, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Accounts are on file at Companies House (micro entity) but not yet parsed into this record.

There are 603 companies in research and experimental development on biotechnology in London with filed accounts; the median reports net assets of £440 and is 6 years old.

02

Ownership and control

3 active
  • Mr Manfredi Giovanni San Martino D'Aglie Di San Germano
    Individual · since 4 January 2022
    • owns 75–100% of shares
    • holds 75–100% of voting rights
    • can appoint or remove directors
  • Dr Christoph Franz Schmidt
    Individual · since 3 March 2025
    • has significant influence or control
  • Mr Ivar Francis Grey De Miremont Wigan
    Individual · since 3 March 2025
    • has significant influence or control

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

03

Key dates

Incorporated
4 January 20224 yrs ago
First accounts due
4 October 20231116 days overdue
Confirmation statement due
18 January 2027in 86 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

04

Activity

SIC 72110
Research and experimental development on biotechnology
SIC 72190
Other research and experimental development on natural sciences and engineering
Accounts type
Micro Entity
05

Financials

No accounts on record

Accounts exist on the register but their figures are not in this dataset yet.

06

Filing and accounts signals

Facts from the register · no rating
  • Incorporated two to five years agoIncorporated 4 January 2022
  • Accounts past their due dateDue 4 October 2023

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

07

Timeline

Newest first
  1. Confirmation statement duein 86 days
  2. First accounts due1116 days overdue
  3. Incorporated
08

Similar companies in London

Same activity (research and experimental development on biotechnology), closest in incorporation date
09

Reminders for BEYOND BLOOD DIAGNOSTICS LTD

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.

Source: Companies House register, snapshot 2026-08-31. Open Government Licence v3.0. View on Companies House. Methodology · About · Markdown.